My get up and go got up and went: fatigue in people with cancer.

Lillian Nail

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Many gaps remain in understanding fatigue across the phases of the cancer experience. These include determining the extent to which fatigue is a presenting or continuing symptom of cancer or a side effect of cancer treatment, identifying those at highest risk of fatigue, defining factors that differentiate between those who do and do not experience fatigue, and characterizing fatigue in special populations such as those with advanced cancer, children, and elders. This article reviews current knowledge of who experiences fatigue, the relationship of fatigue to cancer treatment, and the phenomenon of persistent fatigue following treatment. Critical elements in the research agenda that need to be addressed include the relationship of fatigue to other symptoms of cancer or side effects of treatment, mechanisms underlying fatigue and the development of mechanism-specific approaches to preventing and managing this troublesome symptom.

    Original languageEnglish (US)
    Pages (from-to)72-75
    Number of pages4
    JournalJournal of the National Cancer Institute. Monographs
    Issue number32
    StatePublished - 2004

    Fingerprint

    Fatigue
    Neoplasms
    Therapeutics
    Research
    Population

    Cite this

    My get up and go got up and went : fatigue in people with cancer. / Nail, Lillian.

    In: Journal of the National Cancer Institute. Monographs, No. 32, 2004, p. 72-75.

    Research output: Contribution to journalArticle

    @article{bb2b6be633524548b3a2027c10ecc881,
    title = "My get up and go got up and went: fatigue in people with cancer.",
    abstract = "Many gaps remain in understanding fatigue across the phases of the cancer experience. These include determining the extent to which fatigue is a presenting or continuing symptom of cancer or a side effect of cancer treatment, identifying those at highest risk of fatigue, defining factors that differentiate between those who do and do not experience fatigue, and characterizing fatigue in special populations such as those with advanced cancer, children, and elders. This article reviews current knowledge of who experiences fatigue, the relationship of fatigue to cancer treatment, and the phenomenon of persistent fatigue following treatment. Critical elements in the research agenda that need to be addressed include the relationship of fatigue to other symptoms of cancer or side effects of treatment, mechanisms underlying fatigue and the development of mechanism-specific approaches to preventing and managing this troublesome symptom.",
    author = "Lillian Nail",
    year = "2004",
    language = "English (US)",
    pages = "72--75",
    journal = "NCI Monographs",
    issn = "1052-6773",
    publisher = "Oxford University Press",
    number = "32",

    }

    TY - JOUR

    T1 - My get up and go got up and went

    T2 - fatigue in people with cancer.

    AU - Nail, Lillian

    PY - 2004

    Y1 - 2004

    N2 - Many gaps remain in understanding fatigue across the phases of the cancer experience. These include determining the extent to which fatigue is a presenting or continuing symptom of cancer or a side effect of cancer treatment, identifying those at highest risk of fatigue, defining factors that differentiate between those who do and do not experience fatigue, and characterizing fatigue in special populations such as those with advanced cancer, children, and elders. This article reviews current knowledge of who experiences fatigue, the relationship of fatigue to cancer treatment, and the phenomenon of persistent fatigue following treatment. Critical elements in the research agenda that need to be addressed include the relationship of fatigue to other symptoms of cancer or side effects of treatment, mechanisms underlying fatigue and the development of mechanism-specific approaches to preventing and managing this troublesome symptom.

    AB - Many gaps remain in understanding fatigue across the phases of the cancer experience. These include determining the extent to which fatigue is a presenting or continuing symptom of cancer or a side effect of cancer treatment, identifying those at highest risk of fatigue, defining factors that differentiate between those who do and do not experience fatigue, and characterizing fatigue in special populations such as those with advanced cancer, children, and elders. This article reviews current knowledge of who experiences fatigue, the relationship of fatigue to cancer treatment, and the phenomenon of persistent fatigue following treatment. Critical elements in the research agenda that need to be addressed include the relationship of fatigue to other symptoms of cancer or side effects of treatment, mechanisms underlying fatigue and the development of mechanism-specific approaches to preventing and managing this troublesome symptom.

    UR - http://www.scopus.com/inward/record.url?scp=16544370737&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=16544370737&partnerID=8YFLogxK

    M3 - Article

    C2 - 15263043

    AN - SCOPUS:16544370737

    SP - 72

    EP - 75

    JO - NCI Monographs

    JF - NCI Monographs

    SN - 1052-6773

    IS - 32

    ER -